MedTrace Logo

A Study to Assess Any Potential Interaction Between Colesevelam and Ciclosporin in Healthy Volunteers

NCT00692250 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2015-05-05

No results posted yet for this study

Summary

This study is designed to assess any potential interaction between colesevelam and ciclosporin in healthy volunteers.

Conditions

  • Healthy

Interventions

DRUG

Colesevelam hydrochloride film-coated tablets (Cholestagel)

Sponsors & Collaborators

  • Genzyme, a Sanofi Company

    lead INDUSTRY

Principal Investigators

  • Medical Monitor · Genzyme, a Sanofi Company

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-09-30
Completion
2007-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00692250 on ClinicalTrials.gov